CD8A and neoplasm: In addition, we found a higher CD8+ T cells ratio (66.68%) in T cells of peripheral blood was achieved in the A‐Gel‐Fc‐GOx treatment group compared with other groups (Figure 5d,e; Figure S12, Supporting Information), suggesting the enhanced cellular immunity in tumor‐bearing mice.